問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
呂建興
下載
2022-05-01 - 2025-12-31
Condition/Disease
Test Drug
Participate Sites7Sites
Recruiting7Sites
2015-12-01 - 2026-12-31
Advanced Solid Tumors
Pembrolizumab (MK-3475)
Participate Sites8Sites
Recruiting8Sites
2020-08-31 - 2026-03-31
Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma
Oregovomab
Participate Sites6Sites
Recruiting6Sites
2017-09-01 - 2023-04-20
Participate Sites5Sites
Recruiting4Sites
Terminated1Sites
Division of Obstetrics & Gynecology
全部
